LifeMD Q4 revenue $64.3M (+43% YoY), adj EBITDA $9.0M; FY2025 rev guidance $265-275M

LifeMD, Inc.

Q4 2024 revenue $64.3M (+43% YoY); telehealth revenue $49.9M (+60%); GAAP net loss narrowed to $0.9M from $4.5M.
Adjusted EBITDA $9.0M, up 78% from $5.0M; telehealth adj EBITDA surged 396% to $5.9M.
Telehealth active subscribers 275k (+27% YoY); WorkSimpli subscribers 164k (+3%, sequentially up 3k).
Full-year 2025 guidance: revenue $265-275M, adj EBITDA $30-32M; expects gross margin 88-90%.
Ended 2024 with $35M cash; introduced Q1 2025 guidance rev $61-63M, adj EBITDA $5-7M.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.